HMGN2P5: A Pseudogene Regulating Gene Expression and DNA Replication

Target Name: HMGN2P5

NCBI ID: G727795

HMGN2P5

Other Name(s): high mobility group nucleosomal binding domain 2 pseudogene 5 | High mobility group nucleosomal binding domain 2 pseudogene 5 | HMGN2L5

HMGN2P5: A Pseudogene Regulating Gene Expression and DNA Replication

High mobility group nucleosomal binding domain (HMGN) proteins are a family of non-coding RNAs that play a crucial role in the regulation of gene expression and DNA replication. HMGN2P5 is a pseudogene located on chromosome 17q32.1 and is characterized by its unique HMGN2P5 gene signature, which consists of a highly conserved nuclear localization domain, a unique farnesylated cysteine residue, and a distinct open reading frame.

Expression and Functions

HMGN2P5 is a highly expressed gene that is found in all cell types. It is predominantly expressed in the brain, where it is involved in the regulation of neuronal excitability and synaptic plasticity. In addition to its expression in the brain, HMGN2P5 is also expressed in other tissues, including muscle, heart, and liver.

HMGN2P5 functions as a negative regulator of gene expression by binding to the nucleosome and preventing the loading of specific DNA sequences into the nucleosome. This interaction between HMGN2P5 and the nucleosome results in the repression of gene expression. The binding of HMGN2P5 to the nucleosome is specific and appears to be DNA-protein binding, as demonstrated by the presence of a conserved nucleotide in the binding site.

HMGN2P5 has also been shown to play a role in the regulation of DNA replication. In studies using cell-based assays, it has been shown that HMGN2P5 can interact with the DNA replication machinery and contribute to the regulation of DNA replication efficiency.

Drug Targets and Biomarkers

HMGN2P5 is a promising drug target due to its unique functions and the potential for targeting its activity. One approach to targeting HMGN2P5 is to use small molecules that can modulate the activity of the nucleosome. This approach has been used to study the effects of various small molecules on the regulation of gene expression, including inhibitors of the protein kinase CKP2C, which is known to be a negative regulator of HMGN2P5.

Another approach to targeting HMGN2P5 is to use antibodies that can specifically recognize and label the protein. This approach has been used to study the distribution and function of HMGN2P5 in various tissues and cell types, including the brain.

Conclusion

HMGN2P5 is a pseudogene that has unique functions in the regulation of gene expression and DNA replication. Its regulation of gene expression has been shown to play a role in the regulation of neuronal excitability and synaptic plasticity, as well as the regulation of DNA replication. As a result, HMGN2P5 is a promising drug target with potential for treating a variety of neurological and genetic disorders. Further research is needed to fully understand the functions of HMGN2P5 and to develop effective treatments.

Protein Name: High Mobility Group Nucleosomal Binding Domain 2 Pseudogene 5

The "HMGN2P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGN2P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets